Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « need »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
necrotizing < need < needed  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 36.
[0-20] [0 - 20][0 - 36][20-35][20-40]
Ident.Authors (with country if any)Title
000041 (2014) P. Jayasekera [Royaume-Uni] ; R. Parslew [Royaume-Uni] ; A. Al-Sharqi [Royaume-Uni]A case of tumour necrosis factor‐α inhibitor‐ and rituximab‐induced plantar pustular psoriasis that completely resolved with tocilizumab
000050 (2011) Masaaki Hiura [Japon] ; Shintaro Abe ; Akinari Tabaru ; Shohei Shimajiri ; Kentaro Hanami [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Masaru HaradaCase of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis
000134 (2013) F. Behrens [Allemagne] ; M. Köhm [Allemagne]Personalisierte Medizin bei Zytokin-gerichteten Therapien
000146 (2010) G. Horneff [Allemagne]Juvenile Arthritiden
000150 (2012) O. Psenak [Autriche] ; A. Studnicka-Benke [Autriche] ; R. Greil [Autriche]Sicherheit der Immunsuppressiva
000194 (2007) M. Schneider [Allemagne]Exploring new territory: considering the future
000214 (2012) Fatma Alibaz-Oner [Turquie] ; Sibel Zehra Aydin [Turquie] ; Haner Direskeneli [Turquie]Advances in the diagnosis, assessment and outcome of Takayasu’s arteritis
000249 (2010) R. E. Fischer-Betz [Allemagne] ; M. Schneider [Allemagne]Biologika in Schwangerschaft und Stillzeit
000315 (2011) Kjell Tullus [Royaume-Uni]New developments in the treatment of systemic lupus erythematosus
000535 (2013) Oliver Foot ; Anshuman MalaviyaTreatment of rheumatoid arthritis: current and future
000568 (2014) Koji Chiba [Japon] ; Hiroyuki Yoshitsugu [États-Unis] ; Yuto Kyosaka [Japon] ; Satofumi Iida [Japon] ; Koichiro Yoneyama [Japon] ; Takahiko Tanigawa [Allemagne] ; Takashi Fukushima [Japon] ; Masaki Hiraoka [Japon]A comprehensive review of the pharmacokinetics of approved therapeutic monoclonal antibodies in Japan: Are Japanese phase I studies still needed?
000584 (2012) Chia Chi Sun [États-Unis] ; Valentina Vaja [États-Unis, Italie] ; Jodie L. Babitt [États-Unis] ; Herbert Y. Lin [États-Unis]Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation
000793 (2011) Sheila L. Arvikar [États-Unis] ; Mark C. Fisher [États-Unis]Inflammatory bowel disease associated arthropathy
000908 (2013) S. Celik [États-Unis] ; Y. Yazici [États-Unis]SAT0480 How many patients do we really need to enroll in randomized clinical trials of biologic agents for the treatment of rheumatoid arthritis? An analysis of published trials
000923 (2010) A. Asahina [Japon] ; N. Sakurai [Japon] ; Y. Suzuki [Japon] ; K. Narushima [Japon]Schnitzler’s syndrome with prominent neutrophil infiltration misdiagnosed as Sweet’s syndrome: a typical example of urticarial neutrophilic dermatosis
000A50 (2011) Jisna R. Paul [États-Unis] ; Prabha Ranganathan [États-Unis]Clinical trials in rheumatoid arthritis: a status report from the ClinicalTrials.gov website
000A81 (2013) C. Mercieca [Royaume-Uni] ; G. Bezzina [Malte] ; A. A. Borg [Malte]AB0345 Osmic acid synovectomy; is there still a need for this treatment?
000D23 (2012) Marinos C. Dalakas [États-Unis, Grèce]Biologics and other novel approaches as new therapeutic options in myasthenia gravis: a view to the future
000D39 (2009) David Jayne [Royaume-Uni]Treatment of ANCA‐associated systemic small‐vessel vasculitis
000D77 (2013) M. A. Karsdal ; A. S. Siebuhr ; D. J. Leeming ; I. Byrjalsen ; C. Christiansen [Danemark] ; A. Platt [Royaume-Uni] ; A.-C. Bay-JensenFRI0084 Structural progressors in rheumatoid arthritis identified by serology – identification of the patients in most need of intensive treatment
000E17 (2013) R. H. Osborne [Australie]SP0132 Pro development to improve and deepen understanding of clinical outcomes

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "need" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "need" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    need
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021